Navigation Links
Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model

Mymetics Also Announces Deal for Vaccine Delivery System

NYON, Switzerland, March 29, 2007 /PRNewswire-FirstCall/ -- Mymetics Corporation announced today that the Company's HIV vaccine elicited IgA mucosal antibodies in a non-human primate model. Mucosal IgA antibodies are considered a possible first line of defense against infection by HIV. The data were presented by Sylvain Fleury, Ph.D., Mymetics' Chief Scientific Officer in an oral presentation, "Without Mucosal Adjuvant, Virosomes-gp41 Peptides from the MPR can Elicit Protective Mucosal IgA in Vaccinated Macaques," at the Keystone Symposium, HIV Vaccines: From Basic Research to Clinical Trials. The meeting is being supported by the Bill & Melinda Gates Foundation.

"The results are a striking example of the progress we have seen in applying our vaccine based on the gp41, a well-conserved HIV surface membrane protein," commented Dr. Fleury. "Previously, our team was the first to be able to synthesize a trimeric, soluble and stable formulation of gp41 that could be used in a vaccine. Now, by showing that we can elicit IgA mucosal antibodies in vaginal and rectal tissues, we have taken a major step in being able to prepare materials for a submission to begin studies in human patients. We expect that this submission could take place as early as the third quarter of 2008."

Mymetics also announced that it has signed an exclusive license with Pevion Biotech for the use of Virosomes(R) in the production of its HIV vaccine. Virosomes are a market-approved carrier system for the delivery of pharmaceutically or immunologically active substances, allowing the correct spatial presentation of peptides and proteins and facilitating delivery of Mymetics' HIV vaccine without the use of an adjuvant. Additional details were not disclosed.

Christian Rochet, Mymetics' President and Chief Executive Officer, stated, "We believe that our exclusive agreemen
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
6. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
10. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
11. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur

Post Your Comments:
(Date:11/20/2009)... Ky., Nov. 20 The National Assoc...ay announced a new initiative in the war on metham...PLEx) is a multi-state electronic tracking program...unter (OTC) medicines containing pseudoephedrine i...for NPLEx is based on a system that was developed ...
(Date:11/20/2009)...K, Nov. 20 Reportlinker.com announ... in its catalogue. ,, Blood Pressure Monitorin...nalysis ,, http://www.reportlinker.com/p0164...ents---A-World-Market-Analysis.html#utm_source=prn...ire ,, Measurement of blood pressure is not o...
(Date:11/20/2009)...K, Nov. 20 ,, Reportlinker.com ...ilable in its catalogue. ,, Global Markets for...portlinker.com/p0164741/Global-Markets-for-Breast-...;utm_medium=pr&utm_campaign=prnewswire ,,...udes the spring loaded core needle market and vacu...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved 52905 1Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved 52905 2Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved 52905 3MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 1MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 2MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 3MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 4MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 5MULTAQ 28R 29 28dronedarone 29 for Atrial Fibrillation or Atrial Flutter Now Available in the United States 52903 6Genomic Health to Announce Second Quarter 2009 Financial Results and Host Conference Call on Tuesday August 4 2009 52901 1Genomic Health to Announce Second Quarter 2009 Financial Results and Host Conference Call on Tuesday August 4 2009 52901 2
.... 11 On December 11, 2008, the Joint Advisory Com...FDA) - including the Drug Safety & Risk Manage...mmittee, and the Pulmonary-Allergy Drugs Advisory ... risks of asthma medications containing long-actin...that the benefits of AstraZeneca,s SYMBICORT(R) (b...
...rael, JERSEY CITY, New Jersey and PHILADELPHIA, De... leading,developer of microRNA-based molecular dia...ity of its first diagnostic test, miRview(TM) squa...gh Rosetta Genomics,CLIA-certified lab in Philadel...ntact 1-888-522-7971, or visit the,company,s websi...
Other Medicine Technology:AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 2AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5
(Date:11/22/2009)...mulate blood vessel growth has now been found to b...opment of polyps that characterize one of the most...ns researchers suggests. The finding gives scienti... treat this form of the disease, which typically r...is, a constant irritation and swelling of the nasa...
(Date:11/22/2009)... The Onder Law Firm’s attorneys are offerin...f those who may have experienced heart attack, str...XOLAIR. , St. Louis, MO (... among attorneys offering free XOLAIR case review... and stroke. The attorneys of the Onder Law Firm ...
(Date:11/22/2009)... bacteria are abundant, diverse and constant, but ...ersity of California, San Diego School of Medicine...skin surface trigger a pathway that prevents exces...re actually good for us," said Richard L. Gallo, M...f of UCSD,s Division of Dermatology and the Dermat...
(Date:11/22/2009)...keep eating under control, expert says , ... season means you,ll be faced with a seemingly end...simply give in and eat too much, others deny thems...to navigate between overindulgence and deprivation... Consult Services at Brigham and Women,s Hospital ...
(Date:11/22/2009)... Man & Machine post You Tube video demonstrat...n , Landover, MD (PRWEB) ...ested in learning what a really rugged waterproof ...ally Cool Keyboard vs Washable Competitors Keyboar...ates how the premium, Really Cool Keyboard from M...
Breaking Medicine News(10 mins):Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2
...the drug isotretinoin zaps acne , The most poten...is retinoic acid (13-cis RA; also known as isotret...sm by which it acts. Insight into the mechanisms b...y, who analyzed skin biopsies from patients with a...
...yzer World,s First UPLC PAT System, Tied Directly ...cy, NEW ORLEANS, March 3 Driven by the vision of...ouldn,t previously be,solved, Waters Corporation (...2008 in New Orleans that expand the,boundaries of ...
...e of Diabetes and Digestive and Kidney Diseases (N...formation to raise awareness about diabetes, diges...ong people not yet diagnosed with these illnesses....s. NIDDK is one of the National Institutes of Heal...
...rk Dental, a Twin Cities area,group dental practic...,community for 40-years, announced today that it h...ts practice from its Boston, Massachusetts-based,a...he doctors of Park Dental and a related group call...
...Raise Awareness, Support Families Affected by,Auti...f America, the nation,s leading grassroots autism ... and fastest-growing franchise of giant indoor,inf... combines family fun with raising awareness and su...
...trating its commitment to growth,and innovation, S...manager,and owner of seniors housing communities n...d chief executive officer. His position includes t...unded the company more than 20,years ago -- will c...
Other Medicine News:Health News:JCI online early table of contents: March 3, 2008 2Health News:JCI online early table of contents: March 3, 2008 3Health News:JCI online early table of contents: March 3, 2008 4Health News:JCI online early table of contents: March 3, 2008 5Health News:JCI online early table of contents: March 3, 2008 6Health News:JCI online early table of contents: March 3, 2008 7Health News:JCI online early table of contents: March 3, 2008 8Health News:Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008 2Health News:Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008 3Health News:Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008 4Health News:Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008 5Health News:Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008 6Health News:Park Dental Announces Separation From Its Administrative Service Provider 2Health News:Park Dental Announces Separation From Its Administrative Service Provider 3Health News:Pump It Up and Autism Society of America Launch 'Bounce for Autism' 2Health News:Pump It Up and Autism Society of America Launch 'Bounce for Autism' 3Health News:Senior Lifestyle Corporation Names John Cobb as President and CEO 2
Finlayson Ureteral Access Set
UPJ Occlusion Balloon Catheter Set
Balloon Ureteral Dilator Set
Inflation Device Set
Medicine Products: